⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated
globenewswire.com
OCS
Oculis Appoints Katie Kazem as Chief Legal Officer
globenewswire.com
OCS
Oculis Appoints Katie Kazem as Chief Legal Officer
globenewswire.com
OCS
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
globenewswire.com
OCS
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
globenewswire.com
OCS
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
globenewswire.com
OCS